Utjecaj nosivih uređaja na ishode zdravstvene njege kod kronične bolesti: sistematski pregled.
Journal of medical Internet research
Sažetak istraživanja
Istorijat Hronične bolesti doprinose visokoj stopi invaliditeta i smrtnosti. Angažman pacijenata u samoupravljanju kroničnim bolestima bitna je komponenta modela zdravstvene zaštite kroničnih bolesti. Nosivi uređaji pružaju zdravstvene podatke usmjerene na pacijenta u realnom vremenu, što može pomoći u donošenju odluka u samoupravljanju. Uprkos uočenim prednostima nosivih uređaja u poboljšanju samokontrole hroničnih bolesti, njihov uticaj na ishode zdravstvene zaštite ostaje slabo shvaćen.
Cilj Ovaj pregled je imao za cilj da ispita uticaj nosivih uređaja na ishod zdravstvene zaštite kod osoba sa hroničnim bolestima kroz sistematski pregled literature.
Metode Narativni sistematski pregled je sproveden pretraživanjem 6 baza podataka za randomizirane i opservacijske studije objavljene između 1. januara 2016. i 1. jula 2021., koje su uključivale upotrebu nosive intervencije u grupi hronične bolesti kako bi se procijenio njen uticaj na unaprijed definiranu mjeru ishoda. Ovi ishodi su definirani kao bilo koji utjecaj na iskustvo pacijenta ili kliničara, isplativost ili ishode zdravstvene njege kao rezultat nosive intervencije. Podaci iz uključenih studija izdvojeni su na osnovu 6 ključnih tema, koje su činile osnovu za narativnu kvalitativnu sintezu. Svi rezultati su mapirani prema svakoj komponenti četvorostrukog cilja zdravstvene zaštite. U ovoj studiji slijedile su smjernice izjave PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses).
Rezultati Ukupno je uključeno 30 članaka; studije su prijavile 2446 učesnika (srednja starost: raspon 10,1-74,4 godine), a prikazan je uticaj 14 tipova nosivih predmeta na 18 hroničnih bolesti. Najviše proučavane hronične bolesti bile su dijabetes tipa 2 (4/30, 13%), Parkinsonova bolest (3/30, 10%) i hronični bol u donjem delu leđa (3/30, 10%).
Rezultati su bili mješoviti pri procjeni uticaja na unapred definisani primarni ishod, pri čemu je 50% (15/30) studija pronašlo pozitivan uticaj na proučavani ishod, a 50% (15/30) pokazalo je nulti efekat. U 7% (2/30) studija koje su procjenjivale 2 različita sindroma kronične boli postojao je pozitivan učinak 3D sistema virtuelne stvarnosti na kronični bol. Zapaženi su mješoviti rezultati u utjecaju na kapacitet vježbanja; težina; i biomarkeri bolesti, kao što je hemoglobin A 1c, kod dijabetesa. Proučeno je ukupno 155 ishoda. Većina (139/155, 89,7%) se bavila komponentom ishoda zdravstvene zaštite. Ovo uključuje bol (11/155, 7,5%), kvalitet života (7/155, 4,8%) i fizičku funkciju (5/155, 3,4%). Otprilike 7,7% (12/155) mjera ishoda predstavlja komponentu iskustva pacijenata, a 1,3% (2/155) se odnosi na iskustvo i troškove kliničara.
Zaključci S obzirom na njihovu popularnost i sposobnost, nosivi uređaji mogu igrati integralnu ulogu u liječenju kroničnih bolesti. Međutim, potrebno je dalje istraživanje kako bi se stvorila jaka baza dokaza za sigurnu i efikasnu implementaciju. Probna registracija PROSPERO Međunarodni prospektivni registar sistematskih pregleda CRD42021244562; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=244562.
Prikaži originalni naslov i sažetak na engleskom
The Influence of Wearables on Health Care Outcomes in Chronic Disease: Systematic Review.
Background Chronic diseases contribute to high rates of disability and mortality. Patient engagement in chronic disease self-management is an essential component of chronic disease models of health care. Wearables provide patient-centered health data in real time, which can help inform self-management decision-making. Despite the perceived benefits of wearables in improving chronic disease self-management, their influence on health care outcomes remains poorly understood.
Objective This review aimed to examine the influence of wearables on health care outcomes in individuals with chronic diseases through a systematic review of the literature.
Methods A narrative systematic review was conducted by searching 6 databases for randomized and observational studies published between January 1, 2016, and July 1, 2021, that included the use of a wearable intervention in a chronic disease group to assess its impact on a predefined outcome measure. These outcomes were defined as any influence on the patient or clinician experience, cost-effectiveness, or health care outcomes as a result of the wearable intervention. Data from the included studies were extracted based on 6 key themes, which formed the basis for a narrative qualitative synthesis. All outcomes were mapped against each component of the Quadruple Aim of health care. The guidelines of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement were followed in this study.
Results A total of 30 articles were included; studies reported 2446 participants (mean age: range 10.1-74.4 years), and the influence of 14 types of wearables on 18 chronic diseases was presented. The most studied chronic diseases were type 2 diabetes (4/30, 13%), Parkinson disease (3/30, 10%), and chronic lower back pain (3/30, 10%). The results were mixed when assessing the impact on a predefined primary outcome, with 50% (15/30) of studies finding a positive influence on the studied outcome and 50% (15/30) demonstrating a nil effect. There was a positive effect of 3D virtual reality systems on chronic pain in 7% (2/30) of studies that evaluated 2 distinct chronic pain syndromes. Mixed results were observed in influencing exercise capacity; weight; and biomarkers of disease, such as hemoglobin A 1c , in diabetes. In total, 155 outcomes were studied. Most (139/155, 89.7%) addressed the health care outcomes component. This included pain (11/155, 7.5%), quality of life (7/155, 4.8%), and physical function (5/155, 3.4%). Approximately 7.7% (12/155) of outcome measures represented the patient experience component, with 1.3% (2/155) addressing the clinician experience and cost.
Conclusions Given their popularity and capability, wearables may play an integral role in chronic disease management. However, further research is required to generate a strong evidence base for safe and effective implementation. Trial registration PROSPERO International Prospective Register of Systematic Reviews CRD42021244562; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=244562.
Izvorni podaci
- DOI
- 10.2196/36690
- PMID
- 35776492
- PMCID
- PMC9288104
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom